FDA Inspection
BloodworksBloodworks – FDA Inspection, Dec 11, 2025
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on December 11, 2025, issued by the Seattle District Office, covering biologics.
View Company Profile
ID · 434763ad-6025-46be-a3e0-aafe9ee382fa
Inspection Facts
- Inspection number
- 1294906
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 211.100(b)SOPs not followed / documented
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bloodworks
15| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 16, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 18, 2019 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 7, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 4, 2018 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Bloodworks
- FDA Inspection 1238690 - 2024-05-03
- FDA Inspection 1146276 - 2021-07-16
- FDA Inspection 1087821 - 2019-04-18
- FDA Inspection 1056331 - 2018-06-07
- FDA Inspection 1052060 - 2018-05-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.